| Literature DB >> 33608574 |
Akinori Nishi1, Noriko Kaifuchi2, Chika Shimobori2, Katsuya Ohbuchi2, Seiichi Iizuka2, Aiko Sugiyama2, Keisuke Ogura2, Masahiro Yamamoto2, Haruo Kuroki3, Shigeki Nabeshima4, Ayako Yachie5, Yukiko Matsuoka5, Hiroaki Kitano5.
Abstract
Maoto, a traditional kampo medicine, has been clinically prescribed for influenza infection and is reported to relieve symptoms and tissue damage. In this study, we evaluated the effects of maoto as an herbal multi-compound medicine on host responses in a mouse model of influenza infection. On the fifth day of oral administration to mice intranasally infected with influenza virus [A/PR/8/34 (H1N1)], maoto significantly improved survival rate, decreased viral titer, and ameliorated the infection-induced phenotype as compared with control mice. Analysis of the lung and plasma transcriptome and lipid mediator metabolite profile showed that maoto altered the profile of lipid mediators derived from ω-6 and ω-3 fatty acids to restore a normal state, and significantly up-regulated the expression of macrophage- and T-cell-related genes. Collectively, these results suggest that maoto regulates the host's inflammatory response by altering the lipid mediator profile and thereby ameliorating the symptoms of influenza.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33608574 PMCID: PMC7896050 DOI: 10.1038/s41598-021-82707-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996